Natasha Stephens Münch1, Hsin-Yu Fang2, Jonas Ingermann1, H Carlo Maurer3, Akanksha Anand2, Victoria Kellner2, Vincenz Sahm2, Maria Wiethaler2, Theresa Baumeister2, Frederik Wein2, Henrik Einwächter2, Florian Bolze4, Martin Klingenspor4, Dirk Haller5, Maria Kavanagh6, Joanne Lysaght6, Richard Friedman7, Andrew J Dannenberg8, Michael Pollak9, Peter R Holt10, Sureshkumar Muthupalani11, James G Fox11, Mark T Whary11, Yoomi Lee7, Tony Y Ren7, Rachael Elliot12, Rebecca Fitzgerald13, Katja Steiger14, Roland M Schmid2, Timothy C Wang7, Michael Quante15. 1. Department of Internal Medicine, Technical University of Munich, Germany; Chair of Molecular Nutritional Medicine, Technical University of Munich, Germany. 2. Department of Internal Medicine, Technical University of Munich, Germany. 3. Department of Internal Medicine, Technical University of Munich, Germany; Irvine Cancer Research Center, Columbia University, New York, New York. 4. Chair of Molecular Nutritional Medicine, Technical University of Munich, Germany; EKFZ-Else Kröner-Fresenius Center for Nutritional Medicine, Technical University of Munich, Germany; ZIEL-Institute of Food & Health, Technical University of Munich, Germany. 5. Technical University of Munich, Germany. 6. Department of Surgery, Trinity Translational Medicine Institute, Trinity College Dublin, Ireland. 7. Irvine Cancer Research Center, Columbia University, New York, New York. 8. Weill Cornell Medical College, New York, New York. 9. McGill University, Montreal, Quebec, Canada. 10. Rockefeller University, New York, New York. 11. Massachusetts Institute of Technology, Cambridge, Massachusetts. 12. University of California San Francisco, California. 13. Cambridge University, Cambridge, UK. 14. Institute of Pathology, Technical University of Munich, Germany. 15. Department of Internal Medicine, Technical University of Munich, Germany. Electronic address: michael.quante@tum.de.
Abstract
BACKGROUND & AIMS: Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Progression from BE to cancer is associated with obesity, possibly due to increased abdominal pressure and gastroesophageal reflux disease, although this pathogenic mechanism has not been proven. We investigated whether environmental or dietary factors associated with obesity contribute to the progression of BE to EAC in mice. METHODS: Tg(ED-L2-IL1RN/IL1B)#Tcw mice (a model of BE, called L2-IL1B mice) were fed a chow (control) or high-fat diet (HFD) or were crossbred with mice that express human interleukin (IL) 8 (L2-IL1B/IL8 mice). Esophageal tissues were collected and analyzed for gene expression profiles and by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry. Organoids were established from BE tissue of mice and cultured with serum from lean or obese individuals or with neutrophils from L2-IL1B mice. Feces from mice were analyzed by 16s ribosomal RNA sequencing and compared to 16s sequencing data from patients with dysplasia or BE. L2-IL1B were mice raised in germ-free conditions. RESULTS: L2-IL1B mice fed an HFD developed esophageal dysplasia and tumors more rapidly than mice fed the control diet; the speed of tumor development was independent of body weight. The acceleration of dysplasia by the HFD in the L2-IL1B mice was associated with a shift in the gut microbiota and an increased ratio of neutrophils to natural killer cells in esophageal tissues compared with mice fed a control diet. We observed similar differences in the microbiomes from patients with BE that progressed to EAC vs patients with BE that did not develop into cancer. Tissues from dysplasias of L2-IL1B mice fed the HFD contained increased levels of cytokines that are produced in response to CXCL1 (the functional mouse homolog of IL8, also called KC). Serum from obese patients caused organoids from L2-IL1B/IL8 mice to produce IL8. BE tissues from L2-IL1B mice fed the HFD and from L2-IL1B/IL8 mice contained increased numbers of myeloid cells and cells expressing Cxcr2 and Lgr5 messenger RNAs (epithelial progenitors) compared with mice fed control diets. BE tissues from L2-IL1B mice raised in germ-free housing had fewer progenitor cells and developed less dysplasia than in L2-IL1 mice raised under standard conditions; exposure of fecal microbiota from L2-IL1B mice fed the HFD to L2-IL1B mice fed the control diet accelerated tumor development. CONCLUSIONS: In a mouse model of BE, we found that an HFD promoted dysplasia by altering the esophageal microenvironment and gut microbiome, thereby inducing inflammation and stem cell expansion, independent of obesity.
BACKGROUND & AIMS: Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Progression from BE to cancer is associated with obesity, possibly due to increased abdominal pressure and gastroesophageal reflux disease, although this pathogenic mechanism has not been proven. We investigated whether environmental or dietary factors associated with obesity contribute to the progression of BE to EAC in mice. METHODS: Tg(ED-L2-IL1RN/IL1B)#Tcw mice (a model of BE, called L2-IL1Bmice) were fed a chow (control) or high-fat diet (HFD) or were crossbred with mice that express humaninterleukin (IL) 8 (L2-IL1B/IL8mice). Esophageal tissues were collected and analyzed for gene expression profiles and by quantitative polymerase chain reaction, immunohistochemistry, and flow cytometry. Organoids were established from BE tissue of mice and cultured with serum from lean or obese individuals or with neutrophils from L2-IL1Bmice. Feces from mice were analyzed by 16s ribosomal RNA sequencing and compared to 16s sequencing data from patients with dysplasia or BE. L2-IL1B were mice raised in germ-free conditions. RESULTS: L2-IL1Bmice fed an HFD developed esophageal dysplasia and tumors more rapidly than mice fed the control diet; the speed of tumor development was independent of body weight. The acceleration of dysplasia by the HFD in the L2-IL1Bmice was associated with a shift in the gut microbiota and an increased ratio of neutrophils to natural killer cells in esophageal tissues compared with mice fed a control diet. We observed similar differences in the microbiomes from patients with BE that progressed to EAC vs patients with BE that did not develop into cancer. Tissues from dysplasias of L2-IL1Bmice fed the HFD contained increased levels of cytokines that are produced in response to CXCL1 (the functional mouse homolog of IL8, also called KC). Serum from obesepatients caused organoids from L2-IL1B/IL8mice to produce IL8. BE tissues from L2-IL1Bmice fed the HFD and from L2-IL1B/IL8mice contained increased numbers of myeloid cells and cells expressing Cxcr2 and Lgr5 messenger RNAs (epithelial progenitors) compared with mice fed control diets. BE tissues from L2-IL1Bmice raised in germ-free housing had fewer progenitor cells and developed less dysplasia than in L2-IL1mice raised under standard conditions; exposure of fecal microbiota from L2-IL1Bmice fed the HFD to L2-IL1Bmice fed the control diet accelerated tumor development. CONCLUSIONS: In a mouse model of BE, we found that an HFD promoted dysplasia by altering the esophageal microenvironment and gut microbiome, thereby inducing inflammation and stem cell expansion, independent of obesity.
Authors: Jose M Garcia; Andres E Splenser; Jennifer Kramer; Abeer Alsarraj; Stephanie Fitzgerald; David Ramsey; Hashem B El-Serag Journal: Clin Gastroenterol Hepatol Date: 2013-08-15 Impact factor: 11.382
Authors: Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg Journal: Cancer Discov Date: 2016-04-12 Impact factor: 39.397
Authors: Semir Beyaz; Miyeko D Mana; Jatin Roper; Dmitriy Kedrin; Assieh Saadatpour; Sue-Jean Hong; Khristian E Bauer-Rowe; Michael E Xifaras; Adam Akkad; Erika Arias; Luca Pinello; Yarden Katz; Shweta Shinagare; Monther Abu-Remaileh; Maria M Mihaylova; Dudley W Lamming; Rizkullah Dogum; Guoji Guo; George W Bell; Martin Selig; G Petur Nielsen; Nitin Gupta; Cristina R Ferrone; Vikram Deshpande; Guo-Cheng Yuan; Stuart H Orkin; David M Sabatini; Ömer H Yilmaz Journal: Nature Date: 2016-03-03 Impact factor: 49.962
Authors: Srinand Sundaram; Eun Na Kim; Georgina M Jones; Shamilene Sivagnanam; Monika Tripathi; Ahmad Miremadi; Massimiliano Di Pietro; Lisa M Coussens; Rebecca C Fitzgerald; Young Hwan Chang; Lizhe Zhuang Journal: Front Immunol Date: 2022-05-19 Impact factor: 8.786
Authors: Bettina Kunze; Frederik Wein; Hsin-Yu Fang; Akanksha Anand; Theresa Baumeister; Julia Strangmann; Sophie Gerland; Jonas Ingermann; Natasha Stephens Münch; Maria Wiethaler; Vincenz Sahm; Ana Hidalgo-Sastre; Sebastian Lange; Charles J Lightdale; Aqiba Bokhari; Gary W Falk; Richard A Friedman; Gregory G Ginsberg; Prasad G Iyer; Zhezhen Jin; Hiroshi Nakagawa; Carrie J Shawber; TheAnh Nguyen; William J Raab; Piero Dalerba; Anil K Rustgi; Antonia R Sepulveda; Kenneth K Wang; Roland M Schmid; Timothy C Wang; Julian A Abrams; Michael Quante Journal: Gastroenterology Date: 2020-04-20 Impact factor: 22.682
Authors: Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula Journal: Biomedicines Date: 2021-12-31